dazemevmvctmwosmeonspazahsvizgyadayifsza length 5 56643 page 56643 <!doctype html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">

    <head><base href="https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats/" />
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />
        <meta name="apple-mobile-web-app-capable" content="yes" />
        <meta name="apple-mobile-web-app-title" content="Haiku" />
        
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta content="Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential." name="description" /><meta name="google-site-verification" content="DdVlBNNimIDRpKPPNpIxJTwWxF3svcskMxGSn_9xvgw" /><meta name="google-site-verification" content="DdVlBNNimIDRpKPPNpIxJTwWxF3svcskMxGSn_9xvgw" /><meta name="og:title" content="Oxford Vaccine Group receives £7.8 million in research funding to fight pandemic and epidemic threats" /><meta name="og:description" content="Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential." /><meta name="og:url" content="https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" /><meta name="og:image" content="https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?scale=w1140&amp;ratio=r16x9" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@OxfordVacGroup" /><meta name="twitter:title" content="Oxford Vaccine Group receives £7.8 million in research funding to fight pandemic and epidemic threats" /><meta name="twitter:description" content="Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential." /><meta name="twitter:image" content="https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?scale=w1140&amp;ratio=r16x9" /><meta name="generator" content="Plone - http://plone.org" /><meta itemprop="url" content="https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" /><title>Oxford Vaccine Group receives £7.8 million in research funding to fight pandemic and epidemic threats — Oxford Vaccine Group</title>
        
        
        
        
        
    <link rel="stylesheet" type="text/css" media="screen" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/resourcecollective.cookielawcookielaw-cachekey-bffb33db1fb4f5c0e2d3051133c6eb3c.css" /><link rel="stylesheet" type="text/css" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/themebootstrapcssselect2-cachekey-f307140587bc3cb1efc1dc45ab28efd7.css" /><link rel="stylesheet" type="text/css" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/themebootstrapcssmagnific.popup-cachekey-ddadd94b961e69e14f522489c344a363.css" /><link rel="stylesheet" type="text/css" media="screen" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/resourcecollective.covercsscover-cachekey-c095d9680c735e74f7d009cfe3ced944.css" /><link rel="stylesheet" type="text/css" media="screen" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/resourcehaiku.coveroverlays-cachekey-a87dd1012f50862d35b512469c29b963.css" /><link rel="stylesheet" type="text/css" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/resourcehaiku.coverhaiku.chooser-cachekey-43b10ae3e6f8f9b74a01545fad800231.css" /><link rel="stylesheet" type="text/css" href="https://www.ovg.ox.ac.uk/portal_css/Turnkey%20Theme/resourcehaiku.widgets.imagehaiku.image.widget-cachekey-67bc70dc31b4e98926c8543df32981d8.css" /><link rel="canonical" href="https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" /><link rel="search" href="https://www.ovg.ox.ac.uk/@@search" title="Search this site" /><link rel="shortcut icon" type="image/x-icon" href="https://www.ovg.ox.ac.uk/favicon.ico?v=ab264a3e-0ab9-11ef-8416-0633602177b2" /><link rel="apple-touch-icon" href="https://www.ovg.ox.ac.uk/apple-touch-icon.png?v=ab264a3f-0ab9-11ef-8416-0633602177b2" /><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourcecollective.cookielawcookielaw_disabler-cachekey-fcf7ed7e0fbacafa16b9c755b7f4d0ee.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjsvendorrespond-cachekey-6edb4ec157aa4be66bba0fe02ecd0c95.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourceplone.app.jquery-cachekey-3e6551f409668dc8e104feb2d0ad0ee7.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/vendor/bootstrap.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginsvendorjquery.trunk8-cachekey-9bfca39c7ff589c2ec3fea7149cd85d1.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/plone_javascript_variables-cachekey-9632c2934055cdffc38c06a8963bc075.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourceplone.app.jquerytools-cachekey-1f798d28d8b57ec3184767f82cbeee61.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/mark_special_links-cachekey-1cd446b3aad686cba05345518517caf9.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourceplone.app.discussion.javascriptscomments-cachekey-d75a9a80934018ed3abfd4e5a609cef7.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginsvendorselect2-cachekey-f17b4e31cd8b4e8bb168cc97d96cd914.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/plugins/vendor/jquery.html5-placeholder-shim.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/vendor/hammer.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginshaikujquery.navigation-portlets-cachekey-5b97b3c4eb36ffa1e4646d91709e6645.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginsvendormasonry-cachekey-7456bc196e023e29c1bbc30f38b1a2fd.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginsvendorimagesloaded-cachekey-8a63bd77a14808f615b19a84c2020294.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/plugins/vendor/jquery.lazysizes.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/plugins/vendor/jquery.magnific.popup.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/themebootstrapjspluginsvendorjquery.toc-cachekey-b1e842de1e974ea1393531f57c9d01da.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/++theme++bootstrap/js/turnkey-various.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourcehaiku.profiles.jshaiku.profiles-cachekey-c7217e79be255104137da7b87256da10.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourcehaiku.widgets.imagehaiku.image.widget-cachekey-7bba3fb2574ad84dfc31d865b017f584.js"></script><script type="text/javascript" src="https://www.ovg.ox.ac.uk/portal_javascripts/Turnkey%20Theme/resourcecollective.cookielawcookielaw_banner-cachekey-5a845ee5272154e5f279a22cf0035721.js"></script><script type="text/javascript">
        jQuery(function($){
            if (typeof($.datepicker) != "undefined"){
              $.datepicker.setDefaults(
                jQuery.extend($.datepicker.regional[''],
                {dateFormat: 'mm/dd/yy'}));
            }
        });
        </script><script async="" src="https://www.googletagmanager.com/gtag/js?id=G-TJQWWBZZTG"></script><script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-TJQWWBZZTG');
</script><script async="" src="https://www.googletagmanager.com/gtag/js?id=G-FLBGMLJWG9"></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-FLBGMLJWG9');
</script>
    <link href="https://www.ovg.ox.ac.uk/++theme++sublime-pattens-blue/screen.css" rel="stylesheet" />
  
    <link href="https://www.ovg.ox.ac.uk/++theme++sublime-pattens-blue/style.css" rel="stylesheet" />
  <style type="text/css" class="extra-css" id="global-extra-css">@media only screen and (min-width: 1205px) {
    #primary-logo img {
        max-width : 600px !important;
        margin-top : 20px;
        }
    }
    
    
    #siteaction-contact {
        display : none !important;
    }
    
    #siteaction-accessibility {
        display : none !important;
    }
    
    .media-list.list-horizontal.list-scrolling {
        margin-bottom : -30px !important;
    }
    
    .list-scroll__control {
        top : 20px !important;
        height : 90% !important;    
    }
    
    h1 {
        font-size : 3rem !important;
    }
    .bottom-margin-3px {
            margin-bottom : 3px;
    }

    .social-sharing a.btn {
        border-width: 0px 1px 1px 0px !important;
        border-color: #d6eef4 !important;
        border-radius: 0px;
        padding: 1px 10px;
        color: #0b7893 !important;      
        margin: 10px 3px;
    }

    .social-sharing a.btn:hover {
        color: #2b5fc4 !important;
        outline: 1px solid;
    }

    .glyphicon-rss {
        background-color: #428bca !important;
    }

    .label {
        border-radius: 0px !important;
    }

    #powered-by-haiku {
        display:none !important;
    }
    ul.nav.navbar-nav li.active a {
        color : #00619a !important;
    }

    ul.nav.navbar-nav li.active a::before {
      content: "⏵ ";
      color: #27cec7;
    }</style></head>

    <body class="template-view portaltype-newsitem site-Plone section-news subsection-oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats userrole-anonymous no-toolbar mount-ovg" dir="ltr"><div id="cookienotification">

    <div class="container">
    
        <div class="row">
        
            <div class="col-md-12">
                <h2>
                    Cookies on this website
                </h2>
                
            </div>
        
            <div class="col-md-12">
                <p>
                    We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
                </p>
                
            </div>
    
            <div class="col-md-12">
                <a class="btn btn-success cookie-continue" href="https://www.ovg.ox.ac.uk/@@enable-cookies?&amp;came_from=https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats">Accept all cookies</a>
                <a class="btn btn-danger cookie-disable" href="https://www.ovg.ox.ac.uk/@@disable-cookies?came_from=https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats">Reject all non-essential cookies</a>
                
            </div> 
            
        </div>
    
    </div>
     
</div><div id="site-wrapper" class="container-fluid">

            <div class="modal fade" id="modal" tabindex="-1" role="dialog" aria-hidden="true"></div>

            

            

            <div id="site-header" class="container">

                <div id="site-status"></div>

                

                <header class="row">
                    <div class="col-xs-10 col-sm-6">
                        <a id="primary-logo" title="Oxford Vaccine Group" href="https://www.ovg.ox.ac.uk"><img src="https://www.ovg.ox.ac.uk/images/main/oxford_vaccine_group.png" alt="Oxford Vaccine Group" /></a>
                    </div>
                    <div class="col-sm-6 hidden-xs">
                        <div class="heading-spaced">
                            <div id="site__secondary-logo">
                                
        <a href="https://www.paediatrics.ox.ac.uk/" title="Department of Paediatrics, University of Oxford" target="_blank" rel="noopener"><img src="https://www.ovg.ox.ac.uk/images/main/oxford_uni_paeds.png" alt="Department of Paediatrics, University of Oxford" class="img-responsive logo-secondary" /></a>
    
                            </div>
                            <div id="site-actions">

        <ul class="list-unstyled list-inline text-right">
    
            
    
            
                
                    <li id="siteaction-sitemap">
                        <a href="https://www.ovg.ox.ac.uk/sitemap" title="" accesskey="3">Site Map</a>
                    </li>
                
            
            
                
                    <li id="siteaction-accessibility">
                        <a href="https://www.ovg.ox.ac.uk/accessibility" title="" accesskey="0">Accessibility</a>
                    </li>
                
            
            
                
                    <li id="siteaction-contact">
                        <a href="https://www.ovg.ox.ac.uk/contact-info" title="" accesskey="9">Contact</a>
                    </li>
                
            
            
                
                    <li id="siteaction-cookie-policy">
                        <a href="https://www.ovg.ox.ac.uk/cookies" title="" accesskey="">Cookies</a>
                    </li>
                
            
            
                
                    <li id="siteaction-contact-us">
                        <a href="https://www.ovg.ox.ac.uk/about-us/contact-us" title="" accesskey="">Contact us</a>
                    </li>
                
            
            
                
                    <li id="siteaction-login">
                        <a href="https://www.ovg.ox.ac.uk/Shibboleth.sso/Login?target=https://www.ovg.ox.ac.uk/shibboleth_loggedin?came_from=https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" title="" accesskey="">Log in</a>
                    </li>
                
            
    
        </ul>
    </div><div class="social-following item-actions brand-icons">
        
            
        
        <a href="https://twitter.com/OxfordVacGroup" title="Follow us on Twitter">
            <i class="glyphicon-twitter" aria-label="Twitter"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.facebook.com/oxfordvaccinegroup/" title="Follow us on Facebook">
            <i class="glyphicon-facebook" aria-label="Facebook"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.instagram.com/oxford_vaccinegroup/" title="Follow us on Instagram">
            <i class="glyphicon-instagram" aria-label="Instagram"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.youtube.com/channel/UCYXrteyY2pCqD73meusP1-A" title="Follow us on Youtube">
            <i class="glyphicon-youtube" aria-label="Youtube"></i>
        </a>
    
    
        
    </div>
                        </div>
                    </div>
                    <div class="col-xs-2 visible-xs">
                        <a href="#mmenu" role="button" class="btn btn-default" aria-label="Toggle menu">
                            <i class="glyphicon glyphicon-menu"></i>
                        </a>
                    </div>
                </header>

                <nav role="navigation">
                    <div class="row">
                        <div class="col-sm-10">
                            <div id="site-bar" class="collapse navbar-collapse">

	    <ul class="nav navbar-nav">

            

	            <li class="dropdown" id="portaltab-index_html">
	                <a href="https://www.ovg.ox.ac.uk" title="" data-toggle="">Home</a>
                    
	            </li>

            
            

	            <li class="dropdown" id="portaltab-about">
	                <a href="https://www.ovg.ox.ac.uk/about" title="" data-toggle="" data-hover="dropdown">About us</a>
                    <ul class="dropdown-menu" role="menu">
                        
                            <li>
                                <a href="https://www.ovg.ox.ac.uk/team" title="">Our Team</a>
                            </li>
                        
                    </ul>
	            </li>

            
            

	            <li class="dropdown active" id="portaltab-news">
	                <a href="https://www.ovg.ox.ac.uk/news" title="" data-toggle="" data-hover="dropdown">News</a>
                    <ul class="dropdown-menu" role="menu">
                        
                            <li>
                                <a href="https://www.ovg.ox.ac.uk/upcoming-events" title="">Events</a>
                            </li>
                        
                    </ul>
	            </li>

            
            

	            <li class="dropdown" id="portaltab-research">
	                <a href="https://www.ovg.ox.ac.uk/research" title="" data-toggle="" data-hover="dropdown">Research</a>
                    <ul class="dropdown-menu" role="menu">
                        
                            <li>
                                <a href="https://www.ovg.ox.ac.uk/publications" title="">Publications</a>
                            </li>
                        
                        
                            <li>
                                <a href="https://www.ovg.ox.ac.uk/vaccines-health-and-society-unit-2013-vhas-1" title="">Vaccines and Society Unit</a>
                            </li>
                        
                    </ul>
	            </li>

            
            

	            <li class="dropdown" id="portaltab-support-us">
	                <a href="https://www.ovg.ox.ac.uk/support-us" title="" data-toggle="">Support us</a>
                    
	            </li>

            
            

	            <li class="dropdown" id="portaltab-study">
	                <a href="https://www.ovg.ox.ac.uk/study" title="" data-toggle="">Study with us</a>
                    
	            </li>

            
            

	            <li class="dropdown" id="portaltab-recruiting-studies">
	                <a href="https://www.ovg.ox.ac.uk/recruiting-studies" title="" data-toggle="">Find a Study</a>
                    
	            </li>

            

            

	    </ul>

    </div>
                        </div>
                        <div class="col-sm-2">
                            <form action="https://www.ovg.ox.ac.uk/@@search" id="site-search" class="form-inline" role="form">
                                <div class="input-group">
                                    <label class="sr-only" for="SearchableText">Search</label>
                                    <input type="text" class="form-control" name="SearchableText" id="SearchableText" placeholder="Search" />
                                    <span class="input-group-btn">
                                        <button class="btn" type="submit" aria-label="Search"><i class="glyphicon-search"></i></button>
                                    </span>
                                </div>
                            </form>
                        </div>
                    </div>
                </nav>

                <div class="container">
                    <div class="row">
                        <div class="col-md-12">
                            <ol class="breadcrumb" id="site-breadcrumbs"><li><a title="Home" href="https://www.ovg.ox.ac.uk"><span class="glyphicon glyphicon-home"></span></a></li><li><a href="https://www.ovg.ox.ac.uk/news">News</a></li><li class="active">Oxford Vaccine Group receives £7.8 million in research funding to fight pandemic and epidemic threats</li></ol>
                        </div>
                    </div>
                </div>

            </div>

            <div id="content" class="container ">

                            

                            

            

        <div itemscope="" itemtype="http://schema.org/Article">

            <meta itemprop="url" content="https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" />

            
                <div id="above-page-header">
    

</div>
            

            
                
                
                    
                        <div class="page-header">
                            <div class="row">
                                    
                                <div class="col-xs-12 col-sm-12">
                                    
                                    
                                        <h1>
                                            <span itemprop="name headline">Oxford Vaccine Group receives £7.8 million in research funding to fight pandemic and epidemic threats</span>
                                            <small>
                                                
                                            </small>
                                        </h1>
                                    
                                    
                                    
                
                    <div id="below-page-title">

    <div class="social-sharing">

        
            <a href="http://twitter.com/intent/tweet?text=Oxford%20Vaccine%20Group%20receives%20%C2%A37.8%20million%20in%20research%20funding%20to%20fight%20pandemic%20and%20epidemic%20threats&amp;url=https%3A//www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" title="Twitter" class="btn btn-xs btn-twitter" target="_blank" rel="noopener">
                    <i class="glyphicon-twitter"></i>
                        Share
            </a>
        
        
            <a href="http://www.facebook.com/sharer/sharer.php?u=https%3A//www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats&amp;title=Oxford%20Vaccine%20Group%20receives%20%C2%A37.8%20million%20in%20research%20funding%20to%20fight%20pandemic%20and%20epidemic%20threats" title="Facebook" class="btn btn-xs btn-facebook" target="_blank" rel="noopener">
                    <i class="glyphicon-facebook"></i>
                        Share
            </a>
        
        
            <a href="http://www.linkedin.com/shareArticle?mini=true&amp;url=https%3A//www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats&amp;title=Oxford%20Vaccine%20Group%20receives%20%C2%A37.8%20million%20in%20research%20funding%20to%20fight%20pandemic%20and%20epidemic%20threats&amp;summary=&amp;source=" title="Linkedin" class="btn btn-xs btn-linkedin" target="_blank" rel="noopener">
                    <i class="glyphicon-linkedin"></i>
                        Share
            </a>
        

    </div>


</div>

                    <p class="categories-list">
                        

    
            
        
            
                <span class="label label-primary">COVID-19</span>
            
        
        
            
                <span class="label label-primary">Research</span>
            
        

    


                    </p>
                    
                    <p class="lead" itemprop="datePublished">12 December 2023</p>
                    
                
                                    
                                </div>
                                    
                                
                                            
                            </div>
                        </div>
                    
                    
                    
                    
                 
            

            
                <div id="below-page-header"></div>
            

            
                <div id="above-page-content"></div>
            

            
                <div class="row">
        
                    <div id="site-content" class="col-sm-8">

                        

                            
                                
                            

                            
                                
                                    
                                        <p class="lead" itemprop="description">Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.</p>
                                    
                                
                            

                            
                                
                                    

    <figure class="figure-primary">

        

        

            
                <div class="image-container">
                    

    
        
        <img src="https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?ratio=image&amp;scale=w760" alt="" class="img-responsive" srcset="https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?ratio=image&amp;scale=w1140 1140w, https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?ratio=image&amp;scale=w760 760w, https://www.ovg.ox.ac.uk/images/news/ovg/responsive_image?ratio=image&amp;scale=w320 320w" sizes="100vw" itemprop="image" itemscope="" itemtype="http://schema.org/ImageObject" />
         
    


                    
                </div> 
                
            
        
        

    </figure>


                                
                            
            
                            <div class="row">
                                <div id="site-content-body" class="col-sm-12">
            
                                    
                                        <div class="rich-text" itemprop="articleBody"><p>. The awards will fund research into vaccines against:</p>
<ul>
<li>Chikungunya and mayaro virus</li>
<li>Marburg virus</li>
<li>Plague (<i>Yersinia pestis</i>)</li>
<li>Q Fever (<i>Coxiella burneti)</i></li>
<li>Sudan Ebolavirus</li>
</ul>
<p>The Department of Health and Social Care (DHSC), as part of UK Vaccine Network (UKVN), has made these financial awards to a UK Aid programme, to develop vaccines for diseases with epidemic potential in low and middle-income countries (LMICs).</p>
<p>The development of safe and efficacious vaccination against diseases that cause substantial morbidity and mortality has been one of the foremost scientific advances of the 21st century and OVG, is one of the world’s leading academic vaccine research teams. Its current research includes the study of vaccines for outbreak pathogens and pandemics and, in collaboration with Oxford’s Pandemic Sciences Institute, it draws upon experience and lessons learnt from COVID-19 pandemic to identify and prepare for future pandemic threats.</p>
<p><b>Professor Sir Andrew Pollard, Director of OVG and the Ashall Professor of Infection and Immunity at the Pandemic Sciences Institute</b>, said: “The recent pandemic has highlighted the importance of making vaccines against potential threats to humanity and it is in that context that we are delighted to receive this new funding to drive our vital research into vaccines to protect communities against Marburg virus, Sudan Ebolavirus, plague, Q Fever and chikungunya and mayaro virus. This critical work will help prevent future outbreaks in low- and middle-income countries and offer protection against future pandemics, as previously realised with the Oxford/AstraZeneca vaccine for COVID-19.”</p>
<p><b>Professor Teresa Lambe, Calleva Head of Vaccine Immunology at the Department of Paediatrics, and a Professor of Vaccinology and Immunology at OVG and the Pandemic Sciences Institute</b>, said: “These awards are another important milestone in pandemic prevention. This funding will not only support our efforts to develop life-saving protection for people in low and middle-income countries, but will ensure the UK can respond quickly to potential future pandemic threats.”</p>
<p><b>Dr Young Chan Kim, a Sir Henry Wellcome Fellow and Principal Investigator at OVG</b> who will be leading the Plague, Q-fever, and Alphaviruses programmes under the direction of Professor Pollard said: “We are thrilled to receive these awards to develop new vaccines against these pathogens. This funding will allow us to accelerate our efforts in developing affordable and accessible vaccines that are well-suited for outbreak prevention and general immunisation in low-and-middle-income countries.” </p>
<p>The UKVN programme is funded through UK Official Development Assistance (ODA) via the DHSC. Awards under this programme have been made through competitions run in partnership with BBSRC, EPSRC, Innovate UK and NIHR.</p>
<p><span style="text-decoration: underline; ">Further information:</span></p>
<ul>
<li><b>Marburg virus disease (MVD)</b> is considered one of the deadliest infectious diseases causing viral haemorrhagic fever (VHF) in humans.  Currently, there are no vaccines or specific treatments for MVD. Between 1967 and 2021 there have been fourteen recorded outbreaks, primarily occurring in Uganda.</li>
<li><b>Ebola viruses</b> also cause viral haemorrhagic fever (VHF) in humans with devastating impact on populations and high fatality rates. In September 2022, there was an outbreak of Sudan Ebolavirus (SUDV) in Uganda with 164 cases and 77 deaths. The disease was controlled through case quarantining and contact tracing however, this approach is not always immediately effective as evidenced by the 2013-2016 ebolavirus (Zaire ebolavirus /EBOV) outbreak, which claimed in excess of 11,000 lives.</li>
<li><b>Plague</b> caused by the bacterium <i>Yersinia pestis</i>, is a deadly disease with sporadic cases worldwide and recent outbreaks reported in Africa, China, Russia, and the US, and especially in Democratic Republic of Congo (DRC) and Madagascar. The largest known plague pandemic occurred in the 14th Century and was known as the Great Pestilence (later called the Black Death). It killed half the population of Europe. Antibiotic resistant strains of plague have been described and add to the difficulties in managing outbreaks in resource-limited settings. OVG’s previous work on plague has provided very promising data that will be used to accelerate progress in this programme to provide a new vaccine against this ancient threat.</li>
<li><b>Q fever</b> is caused by the bacterium <i>Coxiella burnetii</i>. It is highly contagious and currently classified as a potential outbreak pathogen/bioterrorism agent.  Q fever cases were extensively reported in LMICs, and the global distribution of Q fever and its burden on regional health security requires safe, efficacious, and affordable vaccines to address. In this programme a new Q fever vaccine candidate will be developed and preparations undertaking for high quality manufacturing and clinical trials. </li>
<li><b>Chikungunya (CHIKV) and mayaro virus (MAYV)</b>: the aim of this project is to develop a bivalent vaccine against two major arthritogenic mosquito-borne viruses. CHIKV and MAYV have spread through Latin America putting the population of over 650 million people at risk of contracting them. The work under this award will aim to develop a bivalent Chikungunya-Mayaro (Chik-May) vaccine using viral-vector and mRNA technologies and to identify the optimal vaccine candidates for a clinical trial.</li>
</ul></div>
                                    
                                    
                                </div>
            
                                
            
                            </div>
            
                            
                                <div id="below-page-body">

    


</div>
                            
                        
        
                    </div>
        
                    <div class="site-sidebar col-sm-4">
        
                        <div id="aside-page-content"></div>
              
                        
                            

    

        <div class="portlet portlet-similaritems  ">

            <h3>Similar stories</h3>

            <div itemscope="" itemtype="http://schema.org/ItemList">
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.ovg.ox.ac.uk/news/how-the-information-security-office-and-the-national-cyber-security-centre-keeps-oxfords-research-secure-post-pandemic" title="Oxford University's Information Security Office (InfoSec) invited the NCSC to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure." itemprop="name" class="state-published">How the Information Security Office and the National Cyber Security Centre keeps Oxford's research secure post-pandemic</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.paediatrics.ox.ac.uk/news/ground-breaking-study-reveals-how-covid-19-vaccines-prevent-severe-disease?ref=image" title="A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated." itemprop="name" target="_blank" class="state-published" rel="noopener external">Ground-breaking study reveals how COVID-19 vaccines prevent severe disease</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.ovg.ox.ac.uk/news/new-trial-to-study-how-the-human-immune-system-adapts-to-2018tolerate2019-malaria-parasites" title="Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness." itemprop="name" class="state-published">New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.ovg.ox.ac.uk/news/oxford-university-professors-to-lecture-on-new-course-in-translational-science-at-three-brazilian-institutions" title="The Department of Paediatrics at the University of Oxford, has entered into an agreement with three Brazilian Universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024." itemprop="name" class="state-published">Oxford University Professors to lecture on new course in 'Translational Science' at three Brazilian institutions</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.ovg.ox.ac.uk/news/fcdo-minister-meets-with-vaccine-researchers" title="Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups." itemprop="name" class="state-published">FCDO Minister meets with vaccine researchers</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
                
                    

    <div class="listing-item listing-item-news" itemscope="" itemprop="itemListElement" itemtype="http://schema.org/NewsArticle">

        <div class="row">

            

            <div class="col-xs-12">

                

    <h2 class="media-heading">
        <a href="https://www.ovg.ox.ac.uk/news/first-in-human-vaccine-trial-for-nipah-virus" title="The University of Oxford has launched a new clinical trial to test a vaccine against the deadly Nipah virus." itemprop="name" class="state-published">First in-human vaccine trial for Nipah virus</a>
    </h2>



                <p class="details">
                    
                </p>

                

                
            
                

            </div>

        </div>

    </div>



                
            </div>

        </div>

    



                        
        
                    </div>
        
                </div>
            

            
                <div id="below-page-content"></div>
            
            
        </div>

    

        
                        </div>

            <footer id="site-footer" class="container" itemscope="" itemtype="http://schema.org/WPFooter">
        <hr />
        


    <div class="row" style="margin-bottom:20px">

        <div class="col-md-4">
            
                <a id="footer-logo" target="_blank" rel="noopener" href="http://www.medsci.ox.ac.uk" title="Oxford University Medical Sciences Division">
                    <img src="https://www.ovg.ox.ac.uk/images/site-logos/footer-logo" alt="" class="img-responsive logo-footer" />
                </a>
            
        </div>

        <div class="col-md-8">
            
                <div id="site-copyright">
                    ©
                    2024
                    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Old Road, Headington, Oxford, UK OX3 7LE
                </div>
            
            
                <ul id="footer-nav" class="list-inline">
                    
                        <li>
                            <a href="http://www.admin.ox.ac.uk/foi" target="_blnak" rel="noopener">Freedom of Information</a>
                        </li>
                    
                    
                        <li>
                            <a href="https://www.ovg.ox.ac.uk/privacy-notice" target="_blank" rel="noopener">Privacy Notice</a>
                        </li>
                    
                    
                        <li>
                            <a href="http://www.ox.ac.uk/copyright" target="_blank" rel="noopener">Copyright Statement</a>
                        </li>
                    
                    
                        <li>
                            <a href="https://www.ovg.ox.ac.uk/accessibility" target="_blank" rel="noopener">Accessibility Statement</a>
                        </li>
                    
                </ul>
            
        </div>
    </div>




    <div class="social-following item-actions brand-icons">
        
            
        
        <a href="https://twitter.com/OxfordVacGroup" title="Follow us on Twitter">
            <i class="glyphicon-twitter" aria-label="Twitter"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.facebook.com/oxfordvaccinegroup/" title="Follow us on Facebook">
            <i class="glyphicon-facebook" aria-label="Facebook"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.instagram.com/oxford_vaccinegroup/" title="Follow us on Instagram">
            <i class="glyphicon-instagram" aria-label="Instagram"></i>
        </a>
    
    
        
        
            
        
        <a href="https://www.youtube.com/channel/UCYXrteyY2pCqD73meusP1-A" title="Follow us on Youtube">
            <i class="glyphicon-youtube" aria-label="Youtube"></i>
        </a>
    
    
        
    </div>







    <div id="site-actions-footer" class="visible-xs-block" style="margin:20px 0">

        <ul class="list-unstyled list-inline text-center">

            
                
                    <li id="siteaction-sitemap">
                        <a href="https://www.ovg.ox.ac.uk/sitemap" title="Site Map" accesskey="3">Site Map</a>
                    </li>
                
            
            
                
                    <li id="siteaction-accessibility">
                        <a href="https://www.ovg.ox.ac.uk/accessibility" title="Accessibility" accesskey="0">Accessibility</a>
                    </li>
                
            
            
                
                    <li id="siteaction-contact">
                        <a href="https://www.ovg.ox.ac.uk/contact-info" title="Contact" accesskey="9">Contact</a>
                    </li>
                
            
            
                
                    <li id="siteaction-cookie-policy">
                        <a href="https://www.ovg.ox.ac.uk/cookies" title="Cookies" accesskey="">Cookies</a>
                    </li>
                
            
            
                
                    <li id="siteaction-contact-us">
                        <a href="https://www.ovg.ox.ac.uk/about-us/contact-us" title="Contact us" accesskey="">Contact us</a>
                    </li>
                
            
            
                
                    <li id="siteaction-login">
                        <a href="https://www.ovg.ox.ac.uk/Shibboleth.sso/Login?target=https://www.ovg.ox.ac.uk/shibboleth_loggedin?came_from=https://www.ovg.ox.ac.uk/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats" title="Log in" accesskey="">Log in</a>
                    </li>
                
            

        </ul>
    </div>





    <div id="powered-by-haiku" class="row">
        <div class="col-xs-12 text-center">
            <a href="http://fry-it.com/haiku" target="_blank" rel="noopener"><img src="https://www.ovg.ox.ac.uk/++theme++bootstrap/images/powered-by-haiku.jpg" alt="powered by Haiku" /></a>
        </div>
    </div>





    



    </footer>

        </div><div id="haiku-mmenu">

            <nav id="mmenu" data-counters="true" data-searchfield="true" data-title="Menu" data-search="true">
                <ul>
                    <li>


    <a href="https://www.ovg.ox.ac.uk/about" class="state-published" title="">
        <span>About us</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/overview-1" class="state-published" title="">
        <span>About Us</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/job-vacancies" class="state-published" title="">
        <span>Job Vacancies</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/vaccsline" class="state-published" title="">
        <span>VACCSline</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/vaccsline/newsletter" class="state-published" title="">
        <span>Past Newsletter</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/get-involved" class="state-published" title="">
        <span>Get Involved</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/get-involved/public-involvement-group" class="state-published" title="">
        <span>Public Involvement Group</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/get-involved/work-with-schools" class="state-published" title="">
        <span>Work with schools</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/contact-us" class="state-published" title="">
        <span>Contact Us</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/cookies" class="state-published" title="">
        <span>Cookies</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/about/support-us" class="state-published" title="">
        <span>Support us</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/news" class="state-published" title="">
        <span>News</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/upcoming-events" class="state-published" title="">
        <span>Events</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research" class="state-published" title="The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.">
        <span>Research</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/systems-vaccinology-systems-biology" class="state-published" title="Our aim is to understand disease pathogenesis and host responses to infection and vaccination.">
        <span>Systems Vaccinology/Systems Biology</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/vaccine-knowledge-project" class="state-published" title="Independent information about vaccines and infectious diseases ( vaccineknowledge.ox.ac.uk )">
        <span>Vaccine Knowledge Project</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/respiratory-syncytial-virus-rsv" class="state-published" title="RSV infection is the most important cause of hospitalisation in infants and one of the leading global causes of infant mortality and as such its prevention through immunisation is a public health priority.">
        <span>Respiratory syncytial virus (RSV)</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/development-and-evaluation-of-vaccines-against-group-b-meningococcal-disease-menb" class="state-published" title="Neisseria meningitidis (Meningitis) is the cause of around 500,000 cases of meningitis and septicaemia every year and disproportionately affects children under two years. We have created new vaccines against MenB. To do this, we have characterised their immunogenicity, identified the optimal vaccine regimen, and evaluated their protective efficacy.">
        <span>Development and evaluation of vaccines against group B meningococcal disease (MenB)</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/vaccines-against-ebola-virus-disease" class="state-published" title="The devastating 2013-2015 outbreak of Ebola Virus disease in West Africa provided the impetus for acceleration of multiple programmes of Ebola Vaccine development.">
        <span>Vaccines against Ebola Virus disease</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/nepal-pneumococcal-impact-assessment-project-1" class="state-published" title="Pneumonia accounts for 15% of deaths among children under-5 years of age globally.  The burden of disease is especially high in South Asia, where one in four children suffer an episode of pneumonia every year. Streptococcus pneumoniae is one of the most significant causative pathogens of pneumonia and other serious invasive diseases.">
        <span>Nepal Pneumococcal Impact Assessment Project</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/group-b-streptococcus" class="state-published" title="Group B streptococcus (GBS) is an important cause of meningitis and sepsis in babies, affecting approximately 1 in 1000 live births in the United Kingdom.">
        <span>Group B streptococcus</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/research/invasive-non-typhoidal-salmonella-disease" class="state-published" title="Non-typhoidal Salmonellae are a group of bacteria that cause gastroenteritis and are found throughout the world. However, these bacteria can sometimes spread beyond the gut into the blood stream, causing invasive non-typhoidal Salmonella (iNTS) disease, a condition which disproportionately affects individuals with weak immune systems (e.g. due to malnutrition or HIV co-infection).">
        <span>Invasive non-typhoidal Salmonella disease</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/publications" class="state-published" title="">
        <span>Publications</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/vaccines-health-and-society-unit-2013-vhas-1" class="state-published" title="">
        <span>Vaccines and Society Unit</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/support-us" class="state-published" title="">
        <span>Support us</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/study" class="state-published" title="We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.">
        <span>Study with us</span>
    </a>

<ul>
<li>


    <a href="https://www.ovg.ox.ac.uk/study/for-undergraduates" class="state-published" title="Dramatically brand robust quality vectors for multimedia based functionalities. Dramatically evolve B2B services rather than innovative models.">
        <span>For undergraduates</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/study/for-postgraduates" class="state-published" title="Efficiently visualize inexpensive networks with leveraged opportunities. Phosfluorescently evolve exceptional opportunities before B2B opportunities.">
        <span>For postgraduates</span>
    </a>

</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/study/study-with-us" class="state-published" title="We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.">
        <span>Study with us</span>
    </a>

</li>

</ul>
</li>
<li>


    <a href="https://www.ovg.ox.ac.uk/recruiting-studies" class="state-published" title="">
        <span>Find a Study</span>
    </a>

</li>

                </ul>
            </nav>

            <script type="text/javascript">
                $(document).ready(function() {
                    var menu = $("#mmenu");
                    menu.mmenu({
                        navbar: {title: menu.data("title")},
                        counters: menu.data("counters"),
                        searchfield: menu.data("search") ? {"resultsPanel": true} : {},
                        navbars: menu.data("search") ? {"content": ["searchfield"]} : {}
                    });
                    // fix for bootstrap modals
                    // http://stackoverflow.com/questions/35038146/bootstrap-modal-and-mmenu-menu-clashing
                    $(".mm-slideout").css("z-index", "auto");
                });
            </script>

         </div>
        <script type="text/javascript">$( document ).ready( () => {
   
    $("[data-class-override]").each( (i,e) => {
        $(e).addClass($(e).attr('data-class-override'))
    });

});</script>
    

    <script type="text/javascript">
        function deleteAllCookies() {
            var cookies = document.cookie.split("; ");
            for (var c = 0; c < cookies.length; c++) {
                if (!HAIKU_ALLOWED_COOKIES.some(v => cookies[c].includes(v))) {
                    var d = window.location.hostname.split(".");
                    while (d.length > 0) {    
                        var cookieBase1 = encodeURIComponent(cookies[c].split(";")[0].split("=")[0]) + '=; expires=Thu, 01-Jan-1970 00:00:01 GMT; domain=' + d.join('.') + '; path=';
                        var cookieBase2 = encodeURIComponent(cookies[c].split(";")[0].split("=")[0]) + '=; expires=Thu, 01-Jan-1970 00:00:01 GMT; domain=.' + d.join('.') + '; path=';
                        var p = location.pathname.split('/');
                        document.cookie = cookieBase1 + '/';
                        document.cookie = cookieBase2 + '/';
                        while (p.length > 0) {
                            document.cookie = cookieBase1 + p.join('/');
                            document.cookie = cookieBase2 + p.join('/');
                            p.pop();
                        };
                        d.shift();
                    }
                }
            }
        };
        if (!(document.cookie.includes('haiku_cookies_enabled'))) {
            deleteAllCookies();
        }
    </script>
    
</body>

</html> contentType 9 text/html url 136 https://www.ovg.ox.ac.uk:443/news/oxford-vaccine-group-receives-ps7-8-million-in-research-funding-to-fight-pandemic-and-epidemic-threats responseCode 3 200 